# NSAIDs and PGE2 Levels in Vitrectomy Patients

> **NCT02361645** · PHASE3 · COMPLETED · sponsor: **Università degli Studi di Brescia** · enrollment: 70 (actual)

## Conditions studied

- Vitreous Inflammation

## Interventions

- **DRUG:** Ketorolac 0.5% eyedrops
- **DRUG:** Indomethacin 0.5% eyedrops
- **DRUG:** Bromfenac 0.09% eyedrops
- **DRUG:** Nepafenac 0.1% eyedrops

## Key facts

- **NCT ID:** NCT02361645
- **Lead sponsor:** Università degli Studi di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-11
- **Final completion:** 2015-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361645, "NSAIDs and PGE2 Levels in Vitrectomy Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02361645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*